165 related articles for article (PubMed ID: 22785213)
1. The DNA binding and accumulation of p53 from breast cancer cell lines and the link with serine 15 phosphorylation.
Ray D; Murphy KR; Gal S
Cancer Biol Ther; 2012 Aug; 13(10):848-57. PubMed ID: 22785213
[TBL] [Abstract][Full Text] [Related]
2. Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status.
Bouchalova P; Nenutil R; Muller P; Hrstka R; Appleyard MV; Murray K; Jordan LB; Purdie CA; Quinlan P; Thompson AM; Vojtesek B; Coates PJ
J Pathol; 2014 Jul; 233(3):238-46. PubMed ID: 24687952
[TBL] [Abstract][Full Text] [Related]
3. p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3.
Lin J; Tang H; Jin X; Jia G; Hsieh JT
Oncogene; 2002 May; 21(19):3082-8. PubMed ID: 12082540
[TBL] [Abstract][Full Text] [Related]
4. Effect of distinct anticancer drugs on the phosphorylation of p53 protein at serine 46 in human MCF-7 breast cancer cells.
Wesierska-Gadek J; Gueorguieva M; Herbacek I; Ranftler C
Ann N Y Acad Sci; 2007 Jan; 1095():45-52. PubMed ID: 17404016
[TBL] [Abstract][Full Text] [Related]
5. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
Liang Y; Wu J; Stancel GM; Hyder SM
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
[TBL] [Abstract][Full Text] [Related]
6. IkappaB kinase beta promotes cell survival by antagonizing p53 functions through DeltaNp73alpha phosphorylation and stabilization.
Accardi R; Scalise M; Gheit T; Hussain I; Yue J; Carreira C; Collino A; Indiveri C; Gissmann L; Sylla BS; Tommasino M
Mol Cell Biol; 2011 Jun; 31(11):2210-26. PubMed ID: 21482671
[TBL] [Abstract][Full Text] [Related]
7. Mutant p53 is constitutively phosphorylated at Serine 15 in UV-induced mouse skin tumors: involvement of ERK1/2 MAP kinase.
Melnikova VO; Santamaria AB; Bolshakov SV; Ananthaswamy HN
Oncogene; 2003 Sep; 22(38):5958-66. PubMed ID: 12955074
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of mutant p53 phosphorylation at serine 15 or serine 315 partially restores the function of wild-type p53.
Sugikawa E; Yazaki N; Tsunoda S; Nakanishi N; Ohashi M
Biochem Biophys Res Commun; 1999 Aug; 261(2):256-63. PubMed ID: 10425175
[TBL] [Abstract][Full Text] [Related]
9. Cadmium induces phosphorylation of p53 at serine 15 in MCF-7 cells.
Matsuoka M; Igisu H
Biochem Biophys Res Commun; 2001 Apr; 282(5):1120-5. PubMed ID: 11302731
[TBL] [Abstract][Full Text] [Related]
10. Characterization of human breast cancer cell lines for the studies on p53 in chemical carcinogenesis.
Huovinen M; Loikkanen J; Myllynen P; Vähäkangas KH
Toxicol In Vitro; 2011 Aug; 25(5):1007-17. PubMed ID: 21457773
[TBL] [Abstract][Full Text] [Related]
11. The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities.
Fiscella M; Zambrano N; Ullrich SJ; Unger T; Lin D; Cho B; Mercer WE; Anderson CW; Appella E
Oncogene; 1994 Nov; 9(11):3249-57. PubMed ID: 7936649
[TBL] [Abstract][Full Text] [Related]
12. Combined Immunohistochemistry of PLK1, p21, and p53 for Predicting TP53 Status: An Independent Prognostic Factor of Breast Cancer.
Watanabe G; Ishida T; Furuta A; Takahashi S; Watanabe M; Nakata H; Kato S; Ishioka C; Ohuchi N
Am J Surg Pathol; 2015 Aug; 39(8):1026-34. PubMed ID: 26171916
[TBL] [Abstract][Full Text] [Related]
13. Constitutive Activation of DNA Damage Checkpoint Signaling Contributes to Mutant p53 Accumulation via Modulation of p53 Ubiquitination.
Frum RA; Love IM; Damle PK; Mukhopadhyay ND; Palit Deb S; Deb S; Grossman SR
Mol Cancer Res; 2016 May; 14(5):423-36. PubMed ID: 26965143
[TBL] [Abstract][Full Text] [Related]
14. MYBBP1A suppresses breast cancer tumorigenesis by enhancing the p53 dependent anoikis.
Akaogi K; Ono W; Hayashi Y; Kishimoto H; Yanagisawa J
BMC Cancer; 2013 Feb; 13():65. PubMed ID: 23388179
[TBL] [Abstract][Full Text] [Related]
15. Modulation of signal transducer and activator of transcription 3 activities by p53 tumor suppressor in breast cancer cells.
Lin J; Jin X; Rothman K; Lin HJ; Tang H; Burke W
Cancer Res; 2002 Jan; 62(2):376-80. PubMed ID: 11809683
[TBL] [Abstract][Full Text] [Related]
16. Ser392 phosphorylation regulates the oncogenic function of mutant p53.
Yap DB; Hsieh JK; Zhong S; Heath V; Gusterson B; Crook T; Lu X
Cancer Res; 2004 Jul; 64(14):4749-54. PubMed ID: 15256442
[TBL] [Abstract][Full Text] [Related]
17. Roscovitine-activated HIP2 kinase induces phosphorylation of wt p53 at Ser-46 in human MCF-7 breast cancer cells.
Wesierska-Gadek J; Schmitz ML; Ranftler C
J Cell Biochem; 2007 Mar; 100(4):865-74. PubMed ID: 17203463
[TBL] [Abstract][Full Text] [Related]
18. Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines.
Park DJ; Nakamura H; Chumakov AM; Said JW; Miller CW; Chen DL; Koeffler HP
Oncogene; 1994 Jul; 9(7):1899-906. PubMed ID: 8208536
[TBL] [Abstract][Full Text] [Related]
19. Restoring p53 active conformation by zinc increases the response of mutant p53 tumor cells to anticancer drugs.
Puca R; Nardinocchi L; Porru M; Simon AJ; Rechavi G; Leonetti C; Givol D; D'Orazi G
Cell Cycle; 2011 May; 10(10):1679-89. PubMed ID: 21508668
[TBL] [Abstract][Full Text] [Related]
20. Hyperoxia activates the ATR-Chk1 pathway and phosphorylates p53 at multiple sites.
Das KC; Dashnamoorthy R
Am J Physiol Lung Cell Mol Physiol; 2004 Jan; 286(1):L87-97. PubMed ID: 12959929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
